Literature DB >> 19236162

Survival in frontotemporal lobar degeneration and related disorders: latent class predictors and brain functional correlates.

B Borroni1, M Grassi, C Agosti, E Premi, A Alberici, B Paghera, S Lucchini, M Di Luca, D Perani, A Padovani.   

Abstract

BACKGROUND: Establishing survival rate in frontotemporal lobar degeneration (FTLD) is a clinical challenge for defining disease outcomes and monitoring therapeutic interventions. Using the latent profile analysis (LPA) approach, we have previously suggested that FTLD patients can be grouped into specific phenotypes- "pseudomanic behavior" (LC1), "cognitive" (LC2), and "pseudodepressed behavior" (LC3)-on the basis of neuropsychological, functional, and behavioral data.
OBJECTIVE: The aim of this study was to evaluate the rate of survival in FTLD, to identify predictors of survival, and to determine the likely usefulness of LPA in defining prognosis.
METHODS: A total of 252 FTLD patients entered the study. A clinical evaluation and standardized assessment were carried out, as well as a brain imaging study. LPA on neuropsychological, functional, and behavioral data was performed. Each patient was followed up over a 5-year period, and institutionalization or death was considered.
RESULTS: The survival rate was associated neither with demographic characteristics, co-morbidities, family history for dementia, nor clinical diagnosis. The presence of the three LC phenotypes was confirmed by LPA. A different survival rate was predicted by LCs, the worse prognosis being found in LC1 (hazard ratio [HR] = 15.7, 95% confidence interval [CI] = 7.2-34.9, p < 0.001, reference LC3). LC2 had a worse prognosis compared to LC3 (HR = 2.07, 95% CI = 0.98-4.37, p = 0.06). Greater hypoperfusion in the orbitomesial frontal cortex was specifically associated with LC1 compared with the other LCs.
CONCLUSIONS: A data-driven approach regarding neuropsychological and behavioral assessment might be useful in clinical practice for defining a FTLD prognosis and hopefully will lead to the possibility of identifying patient groups for the evaluation of treatment response in future trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236162     DOI: 10.1089/rej.2008.0812

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  4 in total

1.  What is the life expectancy in frontotemporal lobar degeneration?

Authors:  Chiadi U Onyike
Journal:  Neuroepidemiology       Date:  2011-11-02       Impact factor: 3.282

2.  Estimating severity of illness and disability in Frontotemporal Dementia: Preliminary analysis of the Dementia Disability Rating (DDR).

Authors:  Chiadi U Onyike; Kelly L Sloane; Shawn F Smyth; Brian S Appleby; David M Blass; Peter V Rabins
Journal:  Acta Neuropsychol       Date:  2011

3.  Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration.

Authors:  Claire J Lansdall; Ian T S Coyle-Gilchrist; Patricia Vázquez Rodríguez; Alicia Wilcox; Eileen Wehmann; Trevor W Robbins; James B Rowe
Journal:  Neurology       Date:  2019-03-06       Impact factor: 9.910

4.  Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes.

Authors:  Alexander G Murley; Matthew A Rouse; Ian T S Coyle-Gilchrist; P Simon Jones; Win Li; Julie Wiggins; Claire Lansdall; Patricia Vázquez Rodríguez; Alicia Wilcox; Karalyn Patterson; James B Rowe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-02-09       Impact factor: 13.654

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.